(R,S)-Carvedilol Glucuronide
A phase II metabolite of carvedilol
| Catalog Number | 27173 |
| Research Area | Product Type|Biochemicals|Antivirals|Protease Inhibitors||Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Product Type|Biochemicals|Small Molecule Inhibitors|Peptidases & Proteases||Product Type|Biochemicals|Xenobiotic Metabolites||Research Area|Cardiovascular System|Cardiovascular Diseases|Heart Failure||Research Area|Cardiovascular System|Cardiovascular Diseases|Hypertension||Research Area|Cardiovascular System|Heart|Arrhythmia||Research Area|Cardiovascular System|Kidney & Renal Disease||Research Area|Cardiovascular System|Vasculature|Vasodilation||Research Area|Immunology & Inflammation|Pulmonary Diseases|COVID-19||Research Area|Infectious Disease|Viral Diseases|Coronaviruses||Research Area|Toxicology & Xenobiotic Metabolism|Drug Metabolites||Research Area|Toxicology & Xenobiotic Metabolism|UDP Glucuronosyltransferases|UGT1A1||Research Area|Toxicology & Xenobiotic Metabolism|UDP Glucuronosyltransferases|UGT2B4||Research Area|Toxicology & Xenobiotic Metabolism|UDP Glucuronosyltransferases|UGT2B7 |
| Molecular Formula | C₃₀H₃₄N₂O₁₀ |
| CAS# | 114869-83-9 |
| Purity | ≥95% |
| Inchi | InChI=1S/C30H34N2O10/c1-38-21-10-4-5-11-22(21)39-14-13-31-15-17(41-30-27(35)25(33)26(34)28(42-30)29(36)37)16-40-23-12-6-9-20-24(23)18-7-2-3-8-19(18)32-20/h2-12,17,25-28,30-35H,13-16H2,1H3,(H,36,37)/t17?,25-,26-,27+,28-,30+/m0/s1 |
| Inchi Key | PUVQFGCELBOSRN-VKTJNCFWSA-N |
| SMILES | COC1=C(OCCNCC(COC2=C3C4=C(NC3=CC=C2)C=CC=C4)O[C@H]5[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O5)C=CC=C1 |
| Size | 500 µg |
| Supplier Page | https://www.caymanchem.com/product/27173 |